Cargando…
Serum galectins as potential biomarkers of inflammatory bowel diseases
The inflammatory bowel diseases (IBD), which include mainly Crohn’s disease (CD) and ulcerative colitis (UC), are common chronic inflammatory conditions of the digestive system. The diagnosis of IBD relies on the use of a combination of factors including symptoms, endoscopy and levels of serum prote...
Autores principales: | Yu, Tony B., Dodd, Susanna, Yu, Lu-Gang, Subramanian, Sreedhar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957193/ https://www.ncbi.nlm.nih.gov/pubmed/31929564 http://dx.doi.org/10.1371/journal.pone.0227306 |
Ejemplares similares
-
Serum Biomarkers for Inflammatory Bowel Disease
por: Chen, Peng, et al.
Publicado: (2020) -
Novel Biomarkers and the Future Potential of Biomarkers in Inflammatory Bowel Disease
por: Duvoisin, Gilles, et al.
Publicado: (2017) -
Serum cytokines MCP-1 and GCS-F as potential biomarkers in pediatric inflammatory bowel disease
por: Ott, Andrea, et al.
Publicado: (2023) -
Serum biomarkers confirming stable remission in inflammatory bowel disease
por: Kessel, Christoph, et al.
Publicado: (2021) -
Serum Galectin-3 as a Potential Predictive Biomarker Is Associated with Poststroke Cognitive Impairment
por: Wang, Qian, et al.
Publicado: (2021)